Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Tarella

Showing results (61-70 of 90) with videos related to

Pageof 9
Sort By:
Leukemia|September 14, 1999
Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissionsC Tarella, P Corradini, M Astolfi, et al.
Bone Marrow Transplantation|October 20, 2009
Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere statusM Ruella, A Rocci, I Ricca, et al.
Leukemia|March 10, 2001
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicityC Tarella, F Zallio, D Caracciolo, et al.
Bone Marrow Transplantation|November 20, 2002
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilizationC Tarella, M Di Nicola, D Caracciolo, et al.
Clinical Radiology|January 11, 2016
Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphomaA Balbo-Mussetto, S Cirillo, R Bruna, et al.
Bone Marrow Transplantation|September 11, 1998
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myelomaI Majolino, P Corradini, R Scimè, et al.
The New England Journal of Medicine|May 1, 1997
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphomaA M Gianni, M Bregni, S Siena, et al.
British Journal of Haematology|December 24, 1997
Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy coursesP Omedè, C Tarella, A Palumbo, et al.
Leukemia|February 18, 2005
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSFI Ricca, M Compagno, M Ladetto, et al.
Haematologica|September 5, 2001
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for LymphomasC Guglielmi, M Martelli, M Federico, et al.
Pageof 9

Showing results (61-70 of 90) with videos related to

Sort By:
Pageof 9
Leukemia|September 14, 1999
Negative immunomagnetic ex vivo purging combined with high-dose chemotherapy with peripheral blood progenitor cell autograft in follicular lymphoma patients: evidence for long-term clinical and molecular remissionsC Tarella, P Corradini, M Astolfi, et al.
Bone Marrow Transplantation|October 20, 2009
Comparative assessment of telomere length before and after hematopoietic SCT: role of grafted cells in determining post-transplant telomere statusM Ruella, A Rocci, I Ricca, et al.
Leukemia|March 10, 2001
High-dose mitoxantrone + melphalan (MITO/L-PAM) as conditioning regimen supported by peripheral blood progenitor cell (PBPC) autograft in 113 lymphoma patients: high tolerability with reversible cardiotoxicityC Tarella, F Zallio, D Caracciolo, et al.
Bone Marrow Transplantation|November 20, 2002
High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilizationC Tarella, M Di Nicola, D Caracciolo, et al.
Clinical Radiology|January 11, 2016
Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphomaA Balbo-Mussetto, S Cirillo, R Bruna, et al.
Bone Marrow Transplantation|September 11, 1998
Allogeneic transplantation of unmanipulated peripheral blood stem cells in patients with multiple myelomaI Majolino, P Corradini, R Scimè, et al.
The New England Journal of Medicine|May 1, 1997
High-dose chemotherapy and autologous bone marrow transplantation compared with MACOP-B in aggressive B-cell lymphomaA M Gianni, M Bregni, S Siena, et al.
British Journal of Haematology|December 24, 1997
Multiple myeloma: reduced plasma cell contamination in peripheral blood progenitor cell collections performed after repeated high-dose chemotherapy coursesP Omedè, C Tarella, A Palumbo, et al.
Leukemia|February 18, 2005
Marked telomere shortening in mobilized peripheral blood progenitor cells (PBPC) following two tightly spaced high-dose chemotherapy courses with G-CSFI Ricca, M Compagno, M Ladetto, et al.
Haematologica|September 5, 2001
Risk-assessment in diffuse large cell lymphoma at first relapse. A study by the Italian Intergroup for LymphomasC Guglielmi, M Martelli, M Federico, et al.
Pageof 9